Bing Xiong

201203, PR China
Shanghai, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Structure-guided discovery of 1H-pyrazolo[3,4-c]pyridin-3-amines as a novel class of hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Structure-guided discovery of 1H-pyrazolo[3,4-c]pyridin-3-amines as a novel class of hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Journal: European journal of medicinal chemistry

Published: May 09, 2026

Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-carboxamides as apelin receptor agonists.

Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-carboxamides as apelin receptor agonists.

Journal: Bioorganic & medicinal chemistry letters

Published: April 02, 2026

Ultrasound-programmable tumor extracellular vesicles delivery system for dual immune-epigenetic therapy against colorectal cancer metastasis.

Ultrasound-programmable tumor extracellular vesicles delivery system for dual immune-epigenetic therapy against colorectal cancer metastasis.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 10, 2026

Antisense oligonucleotide-loaded nanozyme reverses tumor immune suppression through sonogenetic metabolic therapy.

Antisense oligonucleotide-loaded nanozyme reverses tumor immune suppression through sonogenetic metabolic therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 12, 2025

Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells.

Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells.

Journal: Translational oncology

Published: September 09, 2024

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitors.

Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives as potent USP1 inhibitors.

Journal: European journal of medicinal chemistry

Published: April 20, 2024

Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.

Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.

Journal: European journal of medicinal chemistry

Published: December 11, 2023

Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.

Journal: Bioorganic chemistry

Published: June 13, 2023

Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.

Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.

Journal: European journal of medicinal chemistry

Published: February 16, 2023

Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors.

Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors.

Journal: Bioorganic chemistry

Published: July 29, 2022

A rare case of renal tubulocystic oncocytoma.

A rare case of renal tubulocystic oncocytoma.

Journal: Asian journal of surgery

Published: May 12, 2022

A rare case of primary malignant paraganglioma of the urinary bladder.

A rare case of primary malignant paraganglioma of the urinary bladder.

Journal: Asian journal of surgery

Published: May 11, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026